Emergency departments are increasingly seeing patients for repeat opioid-related care.
From 2017 to 2018, there were decreases in overdose death rates involving all opioids, prescription opioids, and heroin, while rates involving synthetic opioids increased.
Among PWID, opioid withdrawal symptoms are associated with increased health risks.
Patients with opioid use disorder (OUD) who receive medications for OUD following endocarditis may experience improved health-related outcomes.
Between 2000 and 2017, unintentional deaths and suicides related to opioid use have increased substantially, whereas overall deaths from have decreased.
The majority of opioid prescribing is attributable to a small proportion of practitioners, according to results published in the BMJ.
Medication treatment with methadone and buprenorphine is associated with a significantly lower risk for overdose death for people with opioid use disorder compared with nonmedication treatment.
Investigators explored concerns with regard to opioid prescribing in compliance with new regulations in a commentary piece.
An enhanced recovery after surgery program complemented by a preemptive pain management program is associated with a decrease in opioid prescriptions at discharge following minimally invasive foregut surgery.
An ad campaign to inform people harmed by the prescription opioid OxyContin as to where they can file claims against maker Purdue Pharma was launched by the company as part of bankruptcy proceedings.